ClearBridge Investments
EPZM

ClearBridge Investments’s Epizyme, Inc EPZM Stock Holding History

ClearBridge Investments’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-228
Closed -$4K – 1211
2014
Q4 		$4K Hold
228
– – ﹤0.01% 1153
2014
Q3 		$6K Hold
228
– – ﹤0.01% 1134
2014
Q2 		$7K Buy
228
+10
+5% +$235 ﹤0.01% 1141
2014
Q1 		$5K Buy
218
+58
+36% +$1.76K ﹤0.01% 1113
2013
Q4 		$3K Hold
160
– – ﹤0.01% 1090
2013
Q3 		$6K Buy
+160
New +$5.42K ﹤0.01% 1057

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

ClearBridge Investments's EPZM Position: Q1 2015 in Review

ClearBridge Investments sold out of Epizyme, Inc (EPZM) in Q1 2015, closing a stake of 228 shares — an estimated $4K sold.

ClearBridge Investments first reported a position in EPZM in Q3 2013 and held it in 6 quarters. The position peaked at $7K in Q2 2014. 103 funds tracked by Wall St. Rank hold EPZM as of Q1 2015.

  • ClearBridge Investments reported no remaining Epizyme, Inc position as of Q1 2015 after selling out during the quarter.
  • ClearBridge Investments sold 228 Epizyme, Inc shares in Q1 2015, an estimated $4K.
  • ClearBridge Investments first reported a position in Epizyme, Inc in Q3 2013 and held it in 6 quarters.
  • ClearBridge Investments's Epizyme, Inc position peaked at $7K in Q2 2014.
  • 103 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2015.

Based on ClearBridge Investments's 13F filing for Q1 2015, filed 15 May 2015.